z-logo
Premium
NAD + : A key metabolic regulator with great therapeutic potential
Author(s) -
Sultani G.,
Samsudeen A. F.,
Osborne B.,
Turner N.
Publication year - 2017
Publication title -
journal of neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.062
H-Index - 116
eISSN - 1365-2826
pISSN - 0953-8194
DOI - 10.1111/jne.12508
Subject(s) - nad+ kinase , nicotinamide adenine dinucleotide , regulator , transcription factor , catabolism , biochemistry , biology , metabolism , nicotinamide phosphoribosyltransferase , microbiology and biotechnology , cofactor , chemistry , enzyme , gene
Nicotinamide adenine dinucleotide ( NAD + ) is a ubiquitous metabolite that serves an essential role in the catabolism of nutrients. Recently, there has been a surge of interest in NAD + biology, with the recognition that NAD + influences many biological processes beyond metabolism, including transcription, signalling and cell survival. There are a multitude of pathways involved in the synthesis and breakdown of NAD + , and alterations in NAD + homeostasis have emerged as a common feature of a range of disease states. Here, we provide an overview of NAD + metabolism and summarise progress on the development of NAD + ‐related therapeutics.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom